Skip to main content
Signal8

MediWound Ltd. (MDWD)

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Sector: Medicinal Chemicals & Botanical Products

Industry: Biotechnology

MediWound Ltd. logo

MediWound Ltd.

NASDAQ:MDWDHealthcare
-4.04%$13.30
AH$13.30+0.00%vs close
Mkt Cap$172.89M
Float11.36M
O/S13M
Vol
$ Vol
RVOL
Inst Own44.8%
SI15.4%
Earnings
Dilution
Financials Summary
Revenue$16.96M
Net Income-$23.88M
Total Assets$86.25M
Free Cash Flow-$20.04M
Debt & Equity
Debt 16%
Equity 84%
Total Debt$8.15M
Total Equity$43.63M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:7Reverse split
    Dec 20, 20227 shares → 1
Balance Sheet Details
Assets$86.25M
Liabilities$42.62M
Accounts Receivable$2.37M
Accounts Payable$3.61M
Inventory$4.09M
PP&E (Net)$25.79M
Goodwill$0
Intangible Assets$33K
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue$16.96M$20.22M$18.69M$26.5M$23.76M$21.76M$31.79M$3.4M$2.5M$1.56M$601K$259K$0$0$0
YoY Growth-16.1%8.2%-29.5%11.5%9.2%-31.5%834.7%36.3%60.2%159.2%132.0%----
Cost of Revenue$13.71M$17.59M$15.11M$13.33M$14.99M$14.22M$11.85M$2.09M$1.58M$2.16M$2.52M$2.79M$335K$268K$0
Gross Profit$3.25M$2.63M$3.58M$13.16M$8.77M$7.54M$19.94M$1.31M$918K-$600K-$1.92M-$2.53M-$335K-$268K$0
Gross Margin19.2%13.0%19.1%49.7%36.9%34.7%62.7%38.6%36.8%-38.5%-319.1%-975.3%---
Research and Development$14.32M$8.88M$7.47M$10.18M$10.26M$7.7M$4.97M$4.07M$5.46M$7.07M$6.02M$5.35M$3.36M$1.32M$3.02M
Selling, General, and Administrative$13.93M$12.91M$11.38M$10.37M$9.45M$8.5M$9.06M$7.94M$9.09M$12.42M$13.23M$13.5M$3.89M$1.14M$1.24M
Other$288K$228K$235K$274K$283K$190K$1.42M-$6.74M$56K$66K$59K$49K$0$0$24K
Total Operating Expenses$28.53M$22.02M$19.08M$20.83M$19.99M$16.39M$15.45M$5.27M$14.61M$19.55M$19.31M$18.9M$7.25M$2.46M$4.29M
Operating Income (EBIT)-$25.28M-$19.38M-$15.5M-$7.66M-$11.22M-$8.84M$4.49M-$3.96M-$13.69M-$20.16M-$21.23M-$21.43M-$7.58M-$2.73M-$4.29M
Operating Margin-149.1%-95.8%-83.0%-28.9%-47.2%-40.6%14.1%-116.4%-548.4%-1293.6%-3531.9%-8273.0%---
Interest Expense$663K$561K$335K$162K$167K$200K$207K$0$0$0$0$57K$1.67M$0$591K
Interest Income$1.86M$2.05M$2.34M$270K$11K$297K$434K$412K$349K$414K$288K$174K$1K$6K$32K
Other Income (Expense)$1.57M-$10.78M$8.97M-$11.86M-$2.3M-$436K-$2.43M-$1.71M-$846K$1.27M-$444K$2.55M-$920K$14.71M-$532K
Income Before Tax (EBT)-$23.71M-$30.16M-$6.53M-$19.52M-$13.52M-$9.28M$2.07M-$5.67M-$14.53M-$18.89M-$21.67M-$18.88M-$8.5M$11.98M-$4.82M
Income Tax Expense$169K$61K$185K$78K$27K$0$0$0$0$0$0$0$0$0$1.88M
Net Income-$23.88M-$30.22M-$6.72M-$19.6M-$13.55M-$9.2M$4.96M-$1.06M-$22.15M-$18.89M-$22.09M-$18.88M-$15.35M$10.94M-$6.17M
Net Income Margin-140.8%-149.5%-35.9%-74.0%-57.0%-42.3%15.6%-31.1%-887.4%-1212.1%-3675.2%-7287.6%---
Supplementary Data
EPS-2.10-3.03-0.75-3.93-3.48-2.381.26-0.28-6.64-6.05-7.13-6.65-5.283.76-2.12
Diluted EPS-2.10-3.03-0.75-3.93-3.48-2.381.26-0.28-6.64-6.05-7.13-6.65-5.283.76-2.12
Weighted Average OS11.38M9.96M9.01M4.99M3.89M3.89M3.88M3.87M3.33M3.12M3.10M2.84M2.91M2.91M2.91M
EBITDA-$21.47M-$27.93M-$4.8M-$18.25M-$11.38M-$7.35M$4.14M-$4.2M-$13.14M-$17.45M-$20.32M-$17.59M-$6.5M$12.25M-$4.1M
EBITDA Margin-126.6%-138.1%-25.7%-68.9%-47.9%-33.8%13.0%-123.4%-526.4%-1120.0%-3381.7%-6791.9%---
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Assets
Current Assets
Cash and Cash Equivalents$4.8M$9.15M$11.87M$33.9M$11.05M$17.38M$7.24M$6.72M$36.07M$28.87M$42.5M$25.42M$7.05M$337K
Short-Term Investments$48.34M$34.01M$29.68M$0$0$4.02M$22.04M$16.92M$0$1.16M$3.27M$39.43M$2.5M$0
Cash and Short-Term Investments$53.14M$43.16M$41.54M$33.9M$11.05M$21.4M$29.46M$23.63M$36.07M$30.03M$45.77M$64.85M$9.55M$337K
Accounts Receivable$2.37M$5.85M$4.42M$9.7M$2.27M$2.84M$4.33M$7.27M$3.44M$2.74M$2.91M$2.02M$2M$1.8M
Inventory$4.09M$2.69M$2.85M$1.96M$1.2M$1.38M$1.61M$1.68M$1.89M$844K$1.72M$1.42M$0$862K
Other Current Assets$0$0$167K$0$0$184K$408K$0$0-$224K-$205K$0$0$0
Total Current Assets$59.96M$52.16M$49.7M$45.84M$14.95M$26.19M$35.62M$32.71M$41.52M$33.61M$50.4M$68.5M$12.06M$3.25M
Long-Term Assets
Property, Plant & Equipment Net$25.79M$20.8M$15.93M$3.58M$4.03M$4.51M$4.53M$2.02M$1.92M$1.28M$1.04M$1.09M$1.14M$1.27M
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$33K$99K$165K$231K$297K$363K$429K$495K$635K$773K$896K$951K$1M$5.09M
Long-Term Investments$0$439K$490K$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$467K$0$183K$364K$469K$0$6K$48K$56K$103K$192K$585K$621K$15.82M
Total Long-Term Assets$26.29M$21.33M$16.76M$4.18M$4.79M$4.88M$4.97M$2.56M$2.62M$2.15M$2.13M$2.62M$2.76M$22.19M
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$86.25M$73.5M$66.46M$50.02M$19.74M$31.07M$40.59M$35.28M$44.13M$35.76M$52.52M$71.12M$14.83M$25.44M
Liabilities
Current Liabilities
Accounts Payable$3.61M$4.1M$4.22M$5.66M$4.69M$2.99M$4.07M$2.71M$3.25M$1.46M$1.12M$1.21M$1.18M$775K
Short-Term Debt$0$418K$0$0$0$0$0$0$0$0$0$0$0$1.55M
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$1.18M$12K$24K$63K$543K$462K$249K$198K$131K$122K$91K$0$0$0
Other Current Liabilities$13.53M$17.73M$1.86M$2.24M$2.83M$2.42M$3.74M$452K$0$2.24M$276K$49K$0$331K
Total Current Liabilities$25.71M$26.54M$10.83M$12.06M$10.72M$8.27M$10.37M$4.9M$5.43M$5.38M$5.21M$3.9M$2.02M$3.36M
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$736K$0$0$119K$1.23M$1.14M$1.16M$988K$1.02M$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$8.76M$8.55M$10.39M$26.2M$12.1M$12.56M$11.91M$20.25M$28.09M$21.59M$23.85M$24.35M$32.61M$6.44M
Total Long-Term Liabilities$16.91M$15.8M$16.74M$27.05M$13.61M$15.53M$15.05M$21.41M$29.08M$22.61M$23.85M$24.35M$32.61M$6.44M
Other Liabilities$0$0$7.3M$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$42.62M$42.34M$34.86M$39.1M$24.33M$23.8M$25.42M$26.3M$34.52M$27.99M$29.05M$28.25M$34.63M$9.8M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$258K$215K$184K$143K$75K$75K$75K$75K$75K$60K$60K$59K$11K$9K
Retained Earnings-$228.93M-$205.05M-$174.82M-$168.11M-$148.51M-$134.96M-$125.76M-$130.72M-$129.41M-$107.26M-$88.38M-$66.29M-$47.41M-$32.06M
Comprehensive Income & Other-$32K-$11K-$18K-$5K-$19K-$40K-$17K-$25K-$38K-$9K-$16K-$18K-$32K$0
Other Stockholders' Equity$272.3M$235.98M$206.23M$178.88M$143.85M$142.15M$140.85M$139.61M$138.95M$114.97M$111.78M$109.1M$27.6M$47.69M
Total Equity$43.63M$31.15M$31.59M$10.91M-$4.58M$7.27M$15.17M$8.97M$9.62M$7.77M$23.47M$42.87M-$19.8M$15.63M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$86.25M$73.5M$66.46M$50.02M$19.74M$31.07M$40.59M$35.28M$44.13M$35.76M$52.52M$71.12M$14.83M$25.44M
Supplementary Data
Total Debt$8.15M$6.93M$6.35M$846K$1.39M$1.74M$2.01M$0$0$0$0$0$0$1.55M
Net Debt$3.35M-$2.22M-$5.52M-$33.05M-$9.65M-$15.63M-$5.24M-$6.72M-$36.07M-$28.87M-$42.5M-$25.42M-$7.05M$1.22M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Operating Activities
Net Income-$23.88M-$30.22M-$6.72M-$19.6M-$13.55M-$9.2M$4.96M-$1.06M-$22.15M-$18.89M-$22.09M-$18.88M-$15.35M$10.94M-$6.17M
Depreciation & Amortization$1.86M$1.48M$1.3M$1.27M$1.24M$1.09M$1.15M$577K$567K$589K$503K$492K$336K$267K$196K
Deferred Income Tax$0$0$0$0$0-$373K-$1.86M$201K-$1.64M$125K$90K-$4.49M-$845K-$15.93M$597K
Stock-Based Compensation$3.11M$3.14M$1.94M$1.95M$1.67M$1.32M$1.23M$645K$1.36M$3.17M$2.66M$4.83M$531K$334K$555K
Changes in Working Capital:
  Accounts Receivable$4.88M-$1.02M$4.76M-$7.22M$166K$1.39M-$3.55M-$211K$28K-$107K-$181K-$67K-$532K$0$782K
  Inventory-$1.36M$187K-$906K-$721K$257K$141K$67K$206K-$1.04M$873K-$273K-$1.42M$0$0$0
  Accounts Payable$2.35M$406K-$594K$414K$1.72M-$1.1M$1.35M-$536K-$135K$331K-$76K$22K$405K$30K-$252K
  Other Working Capital-$1.1M$1.7M-$928K$281K-$1.98M-$492K$6.62M-$467K-$1.3M$885K$805K$2.1M-$262K-$1.98M-$140K
Total Working Capital Change$4.77M$1.27M$2.34M-$7.24M$162K-$61K$4.49M-$1.01M-$2.45M$1.98M$275K$629K-$389K-$1.95M$390K
Other Non-Cash Items-$386K$10.71M-$9.33M$11.74M$1.56M$323K-$1.69M-$11.51M$7.85M-$3.43M-$1.04M$925K$5.98M$1.61M$1.47M
Net Cash from Operating-$14.53M-$13.62M-$10.46M-$11.88M-$8.92M-$6.89M$8.29M-$12.15M-$16.45M-$16.45M-$19.6M-$16.49M-$9.74M-$4.73M-$2.96M
Investing Activities
Capital Expenditures-$5.5M-$6.27M-$6.46M-$555K-$489K-$923K-$792K-$534K-$1.07M-$701K-$406K-$396K-$358K-$413K-$849K
Acquisitions$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments-$14.04M$0$0$0$0$0-$5.05M-$16.61M$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$4M$18.03M$0$0$1.16M$2.11M$36.16M$0$0$0$0
Other Investing Activities$0-$2.12M-$27.86M$74K$35K$274K-$1.05M-$16.51M$349K$2.52M$36.45M-$36.76M-$2.5M$6K-$2.52M
Net Cash from Investing-$19.54M-$8.4M-$34.32M-$481K$3.55M$17.39M-$6.9M-$17.04M$437K$1.82M$36.05M-$37.15M-$2.85M-$407K-$3.37M
Financing Activities
Debt Repaid-$928K---$508K$630K------$3.02M-$1.55M-
Common Stock Issuance$31.05M$22.16M$24.91M$38.39M$3K$0$0$0$22.66M$0$26K$0$15.8M$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$1.43M-$1.84M-$1.99M-$2.63M-$1.05M-$121K-$376K$46K$337K$907K$778K$651K$16.23M$213K$593K
Net Cash from Financing$29.62M$19.39M$22.92M$35.76M-$1.05M-$629K-$1.01M$46K$23M$907K$778K$72.47M$19.24M$1.77M$7.27M
Forex Effect$95K-$84K-$160K-$549K$88K$273K$140K-$205K$226K$86K-$143K-$459K$70K$42K-$1K
Net Change in Cash-$4.36M-$2.71M-$22.03M$22.85M-$6.33M$10.13M$526K-$29.35M$7.2M-$13.64M$17.08M$18.37M$6.72M-$3.33M$934K
Supplementary Data
Operating Cash Flow-$14.53M-$13.62M-$10.46M-$11.88M-$8.92M-$6.89M$8.29M-$12.15M-$16.45M-$16.45M-$19.6M-$16.49M-$9.74M-$4.73M-$2.96M
Capital Expenditure-$5.5M-$6.27M-$6.46M-$555K-$489K-$923K-$792K-$534K-$1.07M-$701K-$406K-$396K-$358K-$413K-$849K
Free Cash Flow-$20.04M-$19.9M-$16.93M-$12.44M-$9.4M-$7.82M$7.5M-$12.69M-$17.53M-$17.15M-$20.01M-$16.89M-$10.1M-$5.14M-$3.81M
Cash at Beginning$9.15M$11.87M$33.9M$11.05M$17.38M$7.24M$6.72M$36.07M$28.87M$42.5M$25.42M$7.05M$337K$3.66M$2.73M
Cash at End$4.8M$9.15M$11.87M$33.9M$11.05M$17.38M$7.24M$6.72M$36.07M$28.87M$42.5M$25.42M$7.05M$337K$3.66M